Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bicycle Therapeutics Plc ADR
(NQ:
BCYC
)
22.71
-0.73 (-3.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Nov 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Bicycle Therapeutics Plc ADR
< Previous
1
2
3
Next >
Navigating 11 Analyst Ratings For Bicycle Therapeutics
October 24, 2024
Via
Benzinga
BCYC: A Promising Play In The Biotech Sector
October 01, 2024
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a...
Via
Talk Markets
Topics
ETFs
Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone
September 06, 2024
RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safety over competitors. The analyst projects ~$2 billion in peak sales by 2033...
Via
Benzinga
In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics
September 06, 2024
Via
Benzinga
The Latest Analyst Ratings For Bicycle Therapeutics
August 07, 2024
Via
Benzinga
BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Expert Ratings For Bicycle Therapeutics
April 10, 2024
Via
Benzinga
The Analyst Landscape: 4 Takes On Bicycle Therapeutics
February 21, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics
December 20, 2023
Via
Benzinga
Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views
May 23, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Gold Falls Sharply; US Composite PMI Surges In May
May 23, 2024
Via
Benzinga
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
May 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 23, 2024
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
November 03, 2023
Via
Benzinga
Where Bicycle Therapeutics Stands With Analysts
September 07, 2023
Via
Benzinga
Expert Ratings for Bicycle Therapeutics
August 04, 2023
Via
Benzinga
Bicycle Therapeutics's Return On Capital Employed Insights
May 17, 2023
Via
Benzinga
BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
February 21, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday
December 15, 2023
U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
14 Analysts Have This to Say About Bicycle Therapeutics
May 11, 2023
Via
Benzinga
Recap: Bicycle Therapeutics Q1 Earnings
May 04, 2023
Via
Benzinga
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
November 30, 2023
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
Why Shares of Bicycle Therapeutics Were Rising on Monday
September 11, 2023
The company said it is working with the FDA to structure a phase 2/3 trial for its bladder cancer therapy.
Via
The Motley Fool
Exposures
Product Safety
Why Bicycle Therapeutics Stock Raced Ahead Today
July 13, 2023
The company's latest attempt at capital raising seems to be having enviable success.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
September 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
July 13, 2023
Via
Benzinga
Stratasys, MillerKnoll, Nikola And Other Big Stocks Moving Higher On Thursday
July 13, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) gained 18% to...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.